NICOLETA NEGOITA: Open Payments
NPI 1306033451 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,036 in 31 payments from 13 companies in 2025. Trend: 2023 $203 · 2024 $16 · 2025 $1,036
Food & beverage: $1,036
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $291 |
| Regeneron Healthcare Solutions, Inc. | 3 | $169 |
| PFIZER INC. | 4 | $124 |
| UCB, Inc. | 3 | $83 |
| Janssen Biotech, Inc. | 2 | $60 |
| ABBVIE INC. | 2 | $58 |
| Galderma Laboratories, L.P. | 3 | $56 |
| GENZYME CORPORATION | 1 | $46 |
| Incyte Corporation | 2 | $44 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $34 |
Products named: DUPIXENT, Winlevi, CIBINQO, Leqselvi, Bimzelx, TREMFYA, RINVOQ, OPZELURA.
Industry payments across MD — which companies pay providers there.
